Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

L Merkens, V Sailer, D Lessel, E Janzen… - Journal of Experimental …, 2022 - Springer
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …

PARP1 at the crossroad of cellular senescence and nucleolar processes

K Kołacz, A Robaszkiewicz - Ageing research reviews, 2024 - Elsevier
Senescent cells that occur in response to telomere shortening, oncogenes, extracellular and
intracellular stress factors are characterized by permanent cell cycle arrest, the …

EZH2 directly methylates PARP1 and regulates its activity in cancer

Q Meng, J Shen, Y Ren, Q Liu, R Wang, Q Li… - Science …, 2024 - science.org
DNA repair dysregulation is a key driver of cancer development. Understanding the
molecular mechanisms underlying DNA repair dysregulation in cancer cells is crucial for …

PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis

Y Qin, X Dong, M Lu, L **g, Q Chen, F Guan, Z **es the heart repair process, eventually leading to heart failure. This …

A new opportunity for “old” molecules: targeting PARP1 activity through a non-enzymatic mechanism

P Iglesias, M Seoane, I Golán-Cancela… - International Journal of …, 2023 - mdpi.com
In recent years, new therapies have been developed based on molecules that target
molecular mechanisms involved in both the initiation and maintenance of the oncogenic …

PARP1: Opportunities of Develo** New Drugs for an Old Target

VM Arce, P Iglesias, JA Costoya - 2024 - Springer
The poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) family of proteins
includes 17 members in mammals, most of which are enzymes that are responsible for …

[PDF][PDF] PARP1: New Drug Development Opportunities for an Old Target

P Iglesias, M Seoane, I Golán-Cancela, M Fraga… - 2023 - preprints.org
In recent years, new therapies have been developed based on molecules that target
molecular mechanisms involved in both the initiation and maintenance of the oncogenic …